drugset / Trial / NCT05729243
Cytisine for Smoking Cessation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to evaluate the safety and effectiveness of cytisine as a smoking cessation treatment in individuals with concurrent alcohol use disorder.
Timeline
- Start
- 2023-02-08
- Primary completion
- 2025-12-12
- Completion
- 2025-12-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytisinicline | Small molecule | 1.5 mg | Oral |